<DOC>
	<DOCNO>NCT01230151</DOCNO>
	<brief_summary>The purpose study assess cognitive performance patient advance Parkinson 's disease receive Deep Brain Stimulation ( DBS ) setting predetermine clinically setting derive patient-specific computational model .</brief_summary>
	<brief_title>Feasibility Study Evaluate Deep Brain Stimulation ( DBS ) Settings Treatment Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patient able willing provide inform consent participate study . The patient 's implant DBS system shall Medtronic , Inc. Activa® System . The Medtronic Activa System may consist either , Soletra® , Kinetra® Activa® RC , Activa® PC Neurostimulator ( ) two DBS Leads ( Model 3387 3389 ) . Patient shall bilateral DBS subthalamic nucleolus ( STN ) . Patient shall stable DBS stimulation without change stimulation parameter less 3 month prior enrollment . Patient shall stable optimal regimen antiparkinson drug therapy le 3 month prior enrollment . Patient , caregiver applicable , able willing available study visit throughout duration study ( e.g . plan relocation residence extend vacation study would prevent compliance study visit schedule ) . Availability , patient 's medical record , Preop MRI high resolution CT artifact reduction less six ( 6 ) week postop . Patient shall Hoehn Yahr stage III bad stimulation medication . Patient shall demonstrate good response LDOPA , define less 30 % improvement UPDRSIII motor exam follow administration LDOPA screen neurological exam . Patient shall demonstrate good response DBS follow administration DBS medication , define improvement UPDRSIII motor score well improvement LDOPA ( determine ) less 20 % bad improvement . Evidence secondary atypical Parkinsonism suggest : stroke , encephalitis , exposure toxin , neuroleptic antipsychotic , neurologic sign upper motor neuron cerebellar involvement , supranuclear palsy . Dementia evidence minimental state examination 24 ( MMSE ≥ 24 ) . Prior participation Intelect Medical GUIDE study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>DBS</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>PD</keyword>
	<keyword>Patients preexist Deep Brain Stimulation ( DBS ) system treatment Parkinson 's disease ( PD )</keyword>
</DOC>